Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing’s syndrome accompanied by hyperglycemia: a case report
Genotype-negative MEN1 typically has a favorable clinical course without a third primary MEN1 manifestation. However, the present case had a symptomatic macroprolactinoma with an apparent elevated glucose level and three manifestations of tumors (pituitary, parathyroid, and adrenal) with invasive PTC, and a delayed diagnosis could have caused crucial deterioration. Clinicians should pay attention to the clinical features of MEN1 including glucose intolerance. In such cases, the treatment of endocrine disorders can lead to the normalization of the glucose level.
Authors
- Mutsuo Yamada (ORCID: https://orcid.org/0000-0003-0380-8593)
- Yuto Yamazaki (ORCID: https://orcid.org/0000-0002-9976-2632)
- Kazuhiro Sugimoto (ORCID: https://orcid.org/0000-0003-4928-2443)
- Yasuhisa Nomura
- Naohiro Sekikawa
- Ryota Wada
- Minoru Inoue
- Naoki Hattori
- Haremaru Kubo
Institutions
- Kansai Medical University (JP)
- Tohoku University (JP)
- Ohta Nishinouchi Hospital (JP)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2024-12-12
- DOI
- https://doi.org/10.3389/fendo.2024.1498991
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00